用多尼佩西尔进行心律不整的主要不良心脏事件:一个系统的综述与元分析
Tina Nham1, Michael Cristian Garcia2,3, Kai La Jennifer Tsang2,4
1Division of Geriatrics, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Journal of the American Geriatrics Society
|April 5, 2024
概括
用于阿尔茨海默病的多尼佩西尔在随机对照试验的元分析中没有发现它会增加主要心脏不良事件 (MACE) 的风险. 需要进行更长期的研究来充分评估心脏安全性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 多尼佩西尔是阿尔茨海默病常见的胆酶抑制剂.
- 基于有限的数据,它被归类为潜在的QT延长药物.
- 这项研究使用高质量的证据评估了多内的心脏安全性.
研究的目的:
- 评估与donepezil相关的前节律不良主要心脏不良事件 (MACE) 的频率和性质.
- 评估donepezil在患有或没有心血管并发症的患者的心脏安全性.
- 为了确定多尼佩西尔是否与安慰剂相比增加MACE的风险.
主要方法:
- 60个随机对照试验 (RCT) 的系统综述和随机效应元分析.
- 包括18岁或以上的患者,将多尼佩西尔与安慰剂进行比较.
- 综合MACE包括死亡率,突然心脏病死亡,心脏骤停,Torsades de pointes,心室动脉节律,或昏迷.
主要成果:
- 与安慰剂相比,多尼佩西尔没有观察到MACE的风险增加 (RR1.08,95% CI 0.88-1.33).
- 死亡率和昏迷/发作是最常见的MACE;没有发生心律失常事件.
- 结果在子组中一致,包括患有心血管疾病的子组,尽管随着更长的随访 (≥52周) 发现了更多事件的趋势.
结论:
- 多尼佩西尔似乎不是心律失常的,并且与MACE的增加无关.
- 对长期治疗的进一步研究是有必要的,以澄清与QT延长相关的临床结果.
- 这些发现支持了关于多尼佩西尔心脏安全概况的知情处方实践.
相关概念视频
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
Mechanism of Cardiac Arrhythmias
918
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
918
Disturbances in Heart Rhythm
950
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
950


